Perspective Therapeutics, Inc. (CATX) Misses Q2 EPS by 16c

Perspective Therapeutics, Inc. (NYSE: CATX) reported Q2 EPS of ($0.18), $0.16 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $530 thousand versus the consensus estimate of $87.75 thousand.

For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.

You May Also Be Interested In

• Lutnick Says 'we Trust Anthropic' - Axios
• C3 AI (AI) call put ratio 4 calls to 1 put with a focus on September 4 weekly 11 calls into quarter results
• Snowflake (SNOW) call put ratio 1.6 calls to 1 put into quarter results